Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

PharmaSGP Holding SE, DE000A2P4LJ5

PharmaSGP Holding SE, DE000A2P4LJ5

16.11.2021 - 07:34:00

PharmaSGP reporting 34% revenue growth and?increased profitability in Q3 2021

16.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: PharmaSGP Holding SE Lochhamer Schlag 21 82166 Gr?felfing

Germany E-mail: ir@pharmasgp.com Internet: https://pharmasgp.com ISIN: DE000A2P4LJ5 WKN: A2P4LJ Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich EQS News ID: 1249193 ? End of News DGAP News Service

1249193??16.11.2021?

@ dgap.de